Separation and identification of norcantharidin metabolites in vivo by GC–MS method

Retention index thresholds for compound matching in GC–MS metabolite profiling

Nadine Strehmel, Jan Hummel, Alexander Erban et al. · Journal of Chromatography B · 2008 · 171 citations

Biochemistry, Gas Chromatography, Medicine +12

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells

Xuhui Liu, I Blazsek, Martine Comisso et al. · European Journal of Cancer · 1995 · 105 citations

Malignant Haemopoietic Cells, Malignant Disease, Oncogenic Agent +9

Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity

Timothy A. Hill, Scott G. Stewart, Benjamin Sauer et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 101 citations

Medicinal Chemistry, Biochemistry, Protein Phosphatase +9

A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells

Yu-Jen Chen, Wei‐Min Chang, Yiwen Liu et al. · Chemico-Biological Interactions · 2009 · 74 citations

Medicine, Matrix Metalloproteinase-9 Expression, Colorectal Cancer +8

An approach to identifying sequential metabolites of a typical phenylethanoid glycoside, echinacoside, based on liquid chromatography–ion trap-time of flight mass spectrometry analysis

Yuxin Wang, Haiping Hao, Guangji Wang et al. · Talanta · 2009 · 69 citations

Sequential Metabolites, Biochemistry, Liquid Chromatography–ion Trap-time +11